The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R/S)-6-(1-Methylpropoxy)-2-sulfanilylpurine ID: ALA4103249
PubChem CID: 137658097
Max Phase: Preclinical
Molecular Formula: C15H18N6O3S
Molecular Weight: 362.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCC(C)Oc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12
Standard InChI: InChI=1S/C15H18N6O3S/c1-3-9(2)24-14-12-13(18-8-17-12)20-15(21-14)19-10-4-6-11(7-5-10)25(16,22)23/h4-9H,3H2,1-2H3,(H2,16,22,23)(H2,17,18,19,20,21)
Standard InChI Key: LSJIMMQWBYSNTG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-0.0833 -18.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3334 -17.5000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.4996 -17.4954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9027 -17.9124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9016 -18.7399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6164 -19.1527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6146 -17.4997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3299 -17.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3348 -18.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1223 -18.9861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6042 -18.3147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1145 -17.6490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1868 -19.1518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4726 -18.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4779 -17.9139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7646 -17.5008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0488 -17.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0507 -18.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7647 -19.1514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6122 -16.6747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3337 -16.6757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8964 -16.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8940 -15.4393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1832 -16.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1783 -15.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
5 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
7 20 1 0
17 2 1 0
2 21 1 0
20 22 1 0
22 23 1 0
22 24 1 0
23 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.42Molecular Weight (Monoisotopic): 362.1161AlogP: 1.92#Rotatable Bonds: 6Polar Surface Area: 135.88Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.94CX Basic pKa: 2.31CX LogP: 2.16CX LogD: 2.15Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -1.33
References 1. Coxon CR, Anscombe E, Harnor SJ, Martin MP, Carbain B, Golding BT, Hardcastle IR, Harlow LK, Korolchuk S, Matheson CJ, Newell DR, Noble ME, Sivaprakasam M, Tudhope SJ, Turner DM, Wang LZ, Wedge SR, Wong C, Griffin RJ, Endicott JA, Cano C.. (2017) Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines., 60 (5): [PMID:28005359 ] [10.1021/acs.jmedchem.6b01254 ]